Alivus Life Sciences Ltd.

With no major difference for the quarter endedDecember 2022 , the total revenue stood at Rs. 5407.31  millions.Profit after tax improved marginally to Rs. 1049.93  millions for the quarter ended December 2022 from Rs. 1037.13 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 1520.64 millions from 1495.98 millions in the quarter ended December 2022.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202212	202112	% Var	202212	202112	% Var	202203	202103	% Var
Sales	5407.31	5224.99	3.49	15399.00	16091.57	-4.30	21232.14	18851.65	12.63
Other Income	66.08	35.34	86.98	261.21	96.09	171.84	147.04	8.11	1713.07
PBIDT	1520.64	1495.98	1.65	4619.84	4834.58	-4.44	6307.64	5918.85	6.57
Interest	1.60	0.61	162.30	4.28	278.37	-98.46	279.62	875.47	-68.06
PBDT	1519.04	1495.37	1.58	4615.56	4556.21	1.30	6028.02	5043.38	19.52
Depreciation	107.63	97.39	10.51	305.77	283.23	7.96	378.77	333.94	13.42
PBT	1411.41	1397.98	0.96	4309.79	4272.98	0.86	5649.25	4709.44	19.96
TAX	361.48	360.85	0.17	1103.75	1074.71	2.70	1462.01	1193.63	22.48
Deferred Tax	29.70	41.49	-28.42	70.75	67.49	4.83	85.74	66.17	29.58
PAT	1049.93	1037.13	1.23	3206.04	3198.27	0.24	4187.24	3515.81	19.10
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	19.60	1150.26
PBIDTM(%)	28.12	28.63	-1.78	30.00	30.04	-0.14	29.71	31.40	-5.38